Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Operating Expenses (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Operating Expenses for 7 consecutive years, with $105.4 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 30.23% to $105.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $378.0 million through Dec 2025, up 13.19% year-over-year, with the annual reading at $378.0 million for FY2025, 13.19% up from the prior year.
  • Operating Expenses hit $105.4 million in Q4 2025 for IDEAYA Biosciences, up from $99.4 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $151.1 million in Q4 2024 to a low of $16.4 million in Q1 2021.
  • Historically, Operating Expenses has averaged $53.1 million across 5 years, with a median of $38.9 million in 2023.
  • Biggest five-year swings in Operating Expenses: surged 229.71% in 2024 and later plummeted 30.23% in 2025.
  • Year by year, Operating Expenses stood at $21.3 million in 2021, then surged by 42.82% to $30.5 million in 2022, then surged by 50.46% to $45.8 million in 2023, then soared by 229.71% to $151.1 million in 2024, then tumbled by 30.23% to $105.4 million in 2025.
  • Business Quant data shows Operating Expenses for IDYA at $105.4 million in Q4 2025, $99.4 million in Q3 2025, and $88.8 million in Q2 2025.